Technical Analysis for APGE - Apogee Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 53.23 | 2.46% | 1.28 |
APGE closed up 2.46 percent on Friday, October 25, 2024, on 53 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 50 DMA | Bullish | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
50 DMA Resistance | Bearish | 2.46% | |
Lower Bollinger Band Walk | Weakness | 2.46% | |
BB Squeeze Ended | Range Expansion | 2.46% | |
Lower Bollinger Band Touch | Weakness | 2.46% | |
Oversold Stochastic | Weakness | 2.46% | |
MACD Bearish Centerline Cross | Bearish | 3.50% |
Alert | Time |
---|---|
Rose Above 10 DMA | 2 days ago |
10 DMA Resistance | 2 days ago |
Rose Above Previous Day's High | 2 days ago |
Up 3% | 2 days ago |
60 Minute Opening Range Breakout | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/12/2024
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Immunology Antibodies Monoclonal Antibodies Occupational Safety And Health Chronic Obstructive Pulmonary Disease Atopic Dermatitis Dermatitis Inflammatory Monoclonal Antibody Therapy Copd
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Immunology Antibodies Monoclonal Antibodies Occupational Safety And Health Chronic Obstructive Pulmonary Disease Atopic Dermatitis Dermatitis Inflammatory Monoclonal Antibody Therapy Copd
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 72.29 |
52 Week Low | 14.22 |
Average Volume | 387,815 |
200-Day Moving Average | 48.12 |
50-Day Moving Average | 52.58 |
20-Day Moving Average | 54.93 |
10-Day Moving Average | 53.86 |
Average True Range | 2.64 |
RSI (14) | 48.19 |
ADX | 20.46 |
+DI | 20.26 |
-DI | 20.41 |
Chandelier Exit (Long, 3 ATRs) | 52.17 |
Chandelier Exit (Short, 3 ATRs) | 58.84 |
Upper Bollinger Bands | 58.89 |
Lower Bollinger Band | 50.97 |
Percent B (%b) | 0.28 |
BandWidth | 14.42 |
MACD Line | -0.21 |
MACD Signal Line | 0.43 |
MACD Histogram | -0.6392 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 56.22 | ||||
Resistance 3 (R3) | 56.29 | 55.36 | 55.72 | ||
Resistance 2 (R2) | 55.36 | 54.60 | 55.33 | 55.55 | |
Resistance 1 (R1) | 54.30 | 54.13 | 54.83 | 54.23 | 55.39 |
Pivot Point | 53.37 | 53.37 | 53.64 | 53.34 | 53.37 |
Support 1 (S1) | 52.31 | 52.61 | 52.84 | 52.24 | 51.07 |
Support 2 (S2) | 51.38 | 52.14 | 51.35 | 50.91 | |
Support 3 (S3) | 50.32 | 51.38 | 50.74 | ||
Support 4 (S4) | 50.25 |